Hersima 150 mg Injection
  1. Home
  2. Pharma Products
  3. Alkem Laboratories Ltd
  4. Hersima 150 mg Injection

Hersima 150 mg Injection

Hersima 150 mg Injection contains trastuzumab, a targeted anticancer medicine used for certain HER2-positive cancers. It is supplied as a 150 mg vial for intravenous infusion. The medicine targets the HER2 protein and helps slow the growth of cancer cells.

BUY NOW

Category

Trastuzumab is a monoclonal antibody that binds to the HER2 receptor on certain cancer cells. By blocking HER2 signaling, it helps control the growth and survival of HER2-positive cancer cells. Hersima may be used for HER2-positive breast cancer and HER2-positive metastatic gastric or gastroesophageal junction cancer. Treatment is administered according to the prescribed oncology protocol with appropriate medical monitoring.

Technical Specification

Specification Details
Active Ingredient Trastuzumab
Strength 150 mg
Dosage Form Powder for Concentrate for Solution for Infusion
Route of Administration Intravenous Infusion
Pack Size 1 Vial of 7.2 mL
Manufacturer Alkem Laboratories Ltd

Product Also Known As

Hersima 150 mg Injection, Trastuzumab 150 mg Injection, Hersima Trastuzumab Injection, Trastuzumab Anticancer Injection, HER2 Targeted Therapy Injection, HER2 Positive Cancer Injection